J&J Family of Companies [EGA] Associate Director, EGA in Shanghai, China
Engage with Shanghai Municipal (and District) Government to address the critical health policy issues and develop the local strategy to support GA and business priorities in Shanghai. Faciliate J&J senior leaders China visit.
Engage with the government agencies, e.g. Health Commission, Medical Insurance Administration and Drug Administration, etc., to support GA and business priorities in Shanghai.
Enhance the relationship and drive the government engagement activities of the key associations/alignment, e.g. industry associations, academics and institutes, etc.
As the GA partner with XJP,JJMC,VC and AMO,etc., to support business priorities and collaborate for policy advocacy and market access
Stay apprised of business goals and strategies in order to assess impact from legislative, executive, regulatory and NGO activities.
Identify health care and other policy developments internationally and in China could impact business and operation.
Review and analyze legislative and executive branch/regulatory activities in consultation with appropriate business and corporate personnel to assess the level of impact to the company.
• Industry experiences: More than 5 – 8 year’s minimum in positions of increasing responsibility and experience in government affairs, corporate affairs, regulatory affairs, market access and public policy in the healthcare industry. • Position experiences: 1. Proven contact network, involvement and success in influencing the development of legislation and strong knowledge of the processes. 2. Proficiency in strategy development, develop action plans and tactical steps. 3. Good analytical, writing, and influencing skills to develop strategies and action plans. 4. Experience on health policy and corporate affairs, etc., is perferable.
• Language Skills：Good presentation / communication skills - Strong ability in written in both Chinese and English.
• Computer Skills: Fluently use lotus, PPT, Word, Excel, etc.
• Others: Shanghainise is preferable
AMO (Hangzhou) Co., Ltd. (7077)